FeesSafety
Pluang+

Simpson Manufacturing Q3 sales rise 2.3%, approves $1B buyback, declares $0.30 dividend

Company Fundamentals
26 Oct 2026, 23:15 WIB
PRNewsWire
View Source
Bullish
Simpson Manufacturing Q3 sales rise 2.3%, approves $1B buyback, declares $0.30 dividend

Simpson Manufacturing reported a 2.3% increase in Q3 2026 net sales to $638.1 million and a slight 0.2% rise in operating income to $141 million. The company approved a new $1 billion share repurchase authorization and declared a $0.30 per share dividend, signaling confidence despite market challenges like higher steel costs and housing affordability pressures. Management highlighted steady demand for value-added solutions and plans for further pricing actions in 2027 to manage costs. The company also noted strong cash flow and a solid operating margin of 22.1%, positioning it well for long-term growth.

Simpson Manufacturing Co., Inc.'s 2026 third quarter financial results provide context for readers. For those following Industrials-sector stocks, Pluang data shows that out of 135 priced US Industrials-sector stocks, 85 rose and 49 fell. Notable movers include ATI Inc. Common Stock at USD 164.34 with a 1-day change of +4.76% and 100% sell order activity, FuelCell Energy Inc at USD 11.05 down 4.53% with 56% buy order activity, and Frontline Plc Ordinary Shares at USD 55.33 up 4.51% with 83% buy order activity. This snapshot is as of Oct 27, 2026 03:01 WIB.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App